Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is not a POS! And oh, tell me about your second argument, the one that says this stock closed down every day... because we closed UP today. We closed UP today!
This is NOT a POS, the MMs aren't playing anybody like anything, and the company is finished running trials on frogs and has graduated to actually doing clinical trials on humans. Humans... not frogs. But frog legs... yummmmmmm.......
DOTB
WE'RE DOWN A SINGLE PENNY!
We've been flat on the day, and now are down a single penny.
The reflexive negativity never stops...
I doubt this prediction will last into 2018...
No, No NO! RIDICULOUS!!!
It's completely irrational to conclude that a recent pop on great volume in a news-pending pre-revenue clinical stage biotech company is somehow a "scam" or a "pump". It's just... ridiculous.
Honestly, isn't a much more believable explanation that someone either just discovered IPIX and wanted to buy in, or, someone has a hunch about soon-to-be-released positive clinical trial data? Isn't one of these explanations far more reasonable than going for the contrived negative conspiracy??? Really...
Reflexive Negativity regarding share price decreases AND INCREASES just doesn't make any sense. Bad is bad and good is bad? Is that the reality you suggest is the truth?
DOTB
No, it's Desperate Unbelievable Duplicity
Consider actually buying shares and playing on the LONG side! Honestly, it has a much, much better reward prospect than playing the other game.
DOTB
NO! Short term share price of a pre-revenue clinical stage biotech company is not a measure of the market's view of management! It simply is not.
And then you throw in all manner of unsupported and ridicules charges such as "toxic", "misleading", "too large salaries", "delay", "broken promise". THAT IS ALL NONSENSE! IT'S MADE UP NONSENSE!
Unsupported, contrived, Reflexive Negativism is not going to be the winner here. To the contrary, the patient, actual, long term shareholder WILL be the winner.
Just wait...
DOTB
Management is doing a wonderful job shepherding three separate drug platform through clinical trials. Just watch...
Except right now -- wrong about not being wrong...
Reality Check: We closed Down 1 1/2 Pennies!
Or, higher.
No, it doesn't, and no, you aren't. Short term price action in this company is not nearly as important as the fact that they have the results of clinical trials due very soon that are widely expected to be positive.
DOTB
Buy stock? That's absurd. Management is focused on the success of the drug platforms and eventual deals with pharmas. The last thing they are concerned with is the short term share price.
DOTB
Management has been fine, excellent even. And again, again... SHORT TERM SHARE PRICE IS NOT THE MOST IMPORTANT THING!
DOTB
Yes, short term price. Because what MATTERS is the excellent science, the three separate drug platforms, and the multiple CLINICAL STAGE trials in progress, some of which are very soon to be reported.
Yes, short term price is not nearly as important as this company's intermediate term potential.
DOTB
Yesterday a one penny lower close was characterized as "cratering" and "heavy selling".
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135989884
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=135989456
Shareholders aren't concerned with every intraday tick. We just aren't.
DOTB
You are welcome to focus on only short term share price fluctuations, while those with vision and those who own shares are far more interested in the vast potential of this company's drugs.
The "fact" is, with developmental and pre-revenue clinical stage biopharma companies, near term share price is not an indication of the potential for huge future success. There are dozens of price charts from successful pharmas that tell this story.
Why continue the obsession with near term share price movements? What's the point? We all can see the price history of this stock. If anything, a lower near term share price is AN ATTRACTION to people who see the potential future blockbuster successes, and wish to hold a piece of the company as a speculative play. I, personally, have used the price weakness over this calendar year to add to my position -- shares I would not have bought had the price remained higher.
Companies like this have two phases -- pre-pharma deal and post-pharma deal. We're now in the pre-deal phase. People who believe in this company, it's science and it's pipeline, WELCOME lower near term share prices.
DOTB
Nothing contained in your post is true.
Shareholders are not impatient, as you seem to be. The company is on track, and the release of clinical trial results imminent. With three separate drug development programs all in clinical trials, the odds of success of at least one are high, and any such success would drive share price very significantly higher.
Patience. P a t i e n c e......... something we shareholders have.
DOTB
This company is not a "POS". And further, you have no idea, nor do I, when a partnership deal might be announced. It could be as early as tomorrow.
Time to SIT TIGHT, wait for IMMINENT NEWS regarding multiple mid to late stage clinical trials across the three separate drug development programs this company is pursuing.
Seriously. Time to SIT TIGHT.
DOTB
Losing one penny on the day is "heavy selling"?
Dude. We closed down ONE SINGLE PENNY.
Wow. Total, Utter, Complete NONSENSE!
Volume was great. Friday was obviously a water shed day. There's just no honest way to read any negatives into Friday's price and volume action.
The only thing "worrisome" is the financial future of anyone short this stock. BS is just going to be ignored. Reflexive negativism is not going to scare anyone. Trying to weave a negative narrative day after day regardless of price action just isn't going to scare anyone.
DOTB
You've proven Reflexive Negativity's a poor investment thesis.
DOTB
Smells like progress about to be made public.
DOTB
Pretty much the GOLD STANDARD for being wrong!
Nothing in your post proved to be the least bit accurate.
DOTB
Wait, thought we were headed for low 60's!
I guess down days are bad AND UP days are bad. All days are bad. Got it.
DOTB
Ready for the glue factory...
Bad when we fall AND when we rally? Just BAD no matter what the price does?
DOTB
and of course, more nonsense, proven wrong.
DOTB
Yeah, no... didn't look like that at all. We closed down one whole penny.
Shorts stand to lose millions and millions of dollars once positive results are released from current Clinical Stage trials.
DOTB
Nonsense! Leo is concerned with the LONG TERM share price, which will appreciate due to successful clinical trials. Short term share price is not the focus of legitimate shareholders...
Leo's doing a great job.
DOTB
DUD, this is utter, complete, one-sided nonsense.
The Bid & Ask are not "fake" and not "garbage".
Uplisting is SECONDARY to conducting successful Clinical Stage trials on the company's three separate drug development programs. The company has a string of successful Clinical stage trials, with fresh study results that are expected to be stellar due within the next few weeks. Uplisting will take care of itself once the first deal is struck.
Success of the company is not guaranteed, but it's far from a "crap shoot". We have three shots on goal, each with arguably better than a 50% chance of success. Pretty damn good odds. However, the word "crap" is applicable in other areas regarding comments posted about this company...
DOTB
Hey DUD! UP 3% Right Now!!!!! Guess your characterization of the quality of the PR is not accurate.
And your characterization of management is shared by virtually no one. Shareholders choose to look to the future to the very large potential of each of the three separate drug development programs now in clinical trials.
Yet all is well and IPIX sits on the verge of an explosive move to all time highs...
DOTB
Straight from DUD! LAST CHANCE FOR SHARES <$1 before the great clinical trial results start to hit!!!
Thanks DUD!
DOTB
100 shares, 15 cents. Cheap thrills for $15...
How does it feel to single handedly pop the share price by 122% for the cost of a case of cheap beer?
DOTB
.70 ! UP 1.5% out of the gate.
How do you know, have you asked one?
Yes. People continue to work hard trying to sink this company with endless, nonsensical FUD.
DOTB